Jean‐Marc Bielser

Merck KGaA, Darmstadt (Germany)

Papers

1

Total Citations

2

H-Index

1

About

Jean-Marc Bielser is a leading figure in bioprocess development, with a focus on advancing perfusion processes for monoclonal antibody production. His work integrates automation, machine learning, and cell culture engineering to create more efficient, scalable manufacturing solutions for biotherapeutics. Bielser’s research is particularly notable for pioneering self-driving development platforms, as exemplified by his 2024 paper on autonomous perfusion process development, which aims to dramatically reduce the time and resources needed to transition from product to process. This work, already garnering attention with early citations, underscores his commitment to accelerating biopharma innovation through robotics and AI-driven experimentation. Beyond this, Bielser has contributed to high-density cell culture systems and continuous manufacturing strategies, helping to shape the future of biologics production. His achievements reflect a deep understanding of both the biological and engineering challenges in bioprocessing, making him a key voice in the push toward more agile, data-driven biomanufacturing. For students and researchers, Bielser’s work offers a compelling vision of how autonomous systems can transform the development of life-saving therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Self-driving development of perfusion processes for monoclonal antibody production
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Merck KGaA, Darmstadt (Germany)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago